Clinical and Biological Significance of CD56 Antigen Expression in Acute Promyelocytic Leukemia-Reference-Cited by-同舟云学术

Clinical and Biological Significance of CD56 Antigen Expression in Acute Promyelocytic Leukemia

Published:2004-09 Issue:9 Volume:45 Page:1783-1789
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ito Shigeki,Ishida Yoji,Oyake Tatsuo,Satoh Mamiko,AOKI Yusei,Kowata Shugo,Uchiyama Toshiyuki,Enomoto Sanae,Sugawara Takeshi,Numaoka Hideharu,Suzuki Keijiro,Murai Kazunori

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190410001683624

Reference34 articles.

1. PATHOGENESIS AND MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA

2. Acute promyelocytic leukemia: a curable disease

3. Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment

4. A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. References;Flow Cytometry of Hematological Malignancies;2021-04-06

2. Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature;Cancers;2020-06-01

3. An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens;Leukemia & Lymphoma;2018-10-15

4. Early mortality in acute promyelocytic leukemia: Potential predictors (Review);Oncology Letters;2018-01-24

5. Prognostic Factors in APL;Acute Promyelocytic Leukemia;2018